Inventor
GEORGE HARTMAN
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
PatentTitleYear
12,509,459Inhibitors of NLRP3 inflammasome202512,435,043Inhibitors of NLRP3 inflammasome202512,421,196Inhibitors of NLRP3 inflammasome202512,215,087Inhibitors of NLRP3 inflammasome202512,129,251N-oxide inhibitors of NLRP3 inflammasome202411,787,805N-oxide inhibitors of NLRP3 inflammasome202311,708,334Inhibitors of NLRP3 inflammasome202311,702,391Inhibitors of NLRP3 inflammasome2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to BIOAGE LABS INC (8)· patent assignee history
2023Patents assigned to HITGEN INC (1)· patent assignee history
2023–2025Based in US· patent location history
2025Patents assigned to HARTMAN GEORGE (1)· patent assignee history
2025Patents assigned to HUMPHRIES PAUL (1)· patent assignee history
2025Patents assigned to WILHELMSEN KEVIN EDWARD LEIF (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOAGE LABS INC | 8 | 2023–2025 |
| HARTMAN GEORGEself | 1 | 2025 |
| HITGEN INC | 1 | 2023 |
| HUMPHRIES PAUL | 1 | 2025 |
| WILHELMSEN KEVIN EDWARD LEIF | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2023–2025 |